臨床研究等提出・公開システム

Effect of food intake containing fenugreek on testosterone

Testfen trial

36

Two of the 40 assigned subjects (1 in the double dose group and 1 in the non-dose group) disagreed, and 38 (test article group; 14 subjects, double dose group; 12 subjects, non-ingestion group; 12 subjects) started the test.

Two people (test article group; 2 subjects) stopped the test due to their own circumstances (work convenience; 2 subjects), and 36 people (12 subjects in each group) completed the test.

none

Adult males with weakened muscles and sexual ability and adult males with metabolic syndrome (both 59 years old or younger) continued to take Fenugreek seed extract-containing processed food "Testfen 18000" for 4 weeks. The AMS score decreased significantly in both the group and the double dose group. There were no significant changes in testosterone levels. A significant decrease was observed in comparison with the non-ingestion group, suggesting an effect on moderate LOH syndrome in AMS score. In addition, there was no significant difference in the amount of change between the test article group and the double dose group, and it was considered that ingestion of a certain amount or more had no effect on the effect.

Adult males continued to ingest processed foods containing fenugreek seed extract for 4 weeks, resulting in a significant decrease in AMS score. There was a significant decrease in comparison with the non-ingestion group. As a result, it was suggested that test product was effective for people with moderate LOH syndrome.

Aug. 24, 2020

Aug. 24, 2020

https://www.shinryo-to-shinyaku.com/db/pdf/sin_0057_08_0834.pdf

No

none

https://jrct.mhlw.go.jp/latest-detail/jRCTs031190171

Miyata Akinobu

Nihonbashi M's Clinic

9F, 2-2-8 Nihonbashi, Tyuuouku, Tokyo

info@nihonbashi-ms-clinic.com

Kaneko Takeshi

Japan Clinical Trial Association

5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo

+81-3-6302-0593

jacta@usjri.com

Complete

Jan. 10, 2020

Interventional

randomized controlled trial

single blind

dose comparison control

parallel assignment

treatment purpose

1. Subjects who feel muscle loss or muscle weakness
2. Subjects with metabolic syndrome
3. Subjects who are aware of a decrease in the frequency of erections in the morning

1. Subjects with food allergies
2. Subjects with vulnerable
3. Chronic fatigue subjects
4. Subjects before and after surgery due to visceral diseases

Male

Healthy adult male

Three groups: a group that takes 3 test samples for 4 weeks, a group that takes 6 test samples for 4 weeks, and a group that does not take test products

circulating testosterone, Aging males symptom(AMS) score

+81-3-5326-3129

Dec. 19, 2019

none